Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease - authors' reply
Aliment Pharmacol Ther
.
2019 Feb;49(4):477-478.
doi: 10.1111/apt.15125.
Authors
Ruth de Francisco
1
,
Andrés Castaño-García
1
,
Sabino Riestra
1
Affiliation
1
Gastroenterology, Hospital Universitario Central de Asturias, Oviedo, Spain.
PMID:
30689254
DOI:
10.1111/apt.15125
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Epstein-Barr Virus Infections*
Herpesvirus 4, Human
Humans
Inflammatory Bowel Diseases*